Global Injection Lipolysis Market
Global Injection Lipolysis Market

Injection Lipolysis Comprehensive Study by Drug (Deoxycholic Acid, Phosphatidylcholine, Others), Treatment Type (Facial Fat Deposits, Submental Fat, Upper Arm Fat, Abdominal Fat, Thighs Fat, Knee Fat, Buttock Fat, Others), End User (Hospitals, Dermatology and Cosmetic Clinics, Ambulatory Surgical Centers)

Injection Lipolysis Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

May 2021 Edition 236 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Injection Lipolysis Market Scope
Injection lipolysis is a controversial cosmetic procedure in which medicate mixtures are infused into patients with the goal of destroying fat cells. It is additionally connected in cosmetic surgeries to the patients to reduce the number of fat cells. Injection lipolysis is a non-surgical alternative in which drug blends such as deoxycholic acid, in combination with vitamin E, l-carnitine, collagenase, isoproterenol, and hyaluronidase are infused to destroy fat cells. In the US and in Canada the only FDA-approved fat dissolving injection is deoxycholic acid and it is indicated only for the treatment of sub mental fat known as the double chin. Injection lipolysis is a method using thin needles injecting into the skin solutions containing substances that break down fats in fat cells. These arrangements usually contain phosphatidylcholine. It is a natural substance, which is obtained from the soybeans but also is naturally in the human body.

The Injection Lipolysis market study is segmented and major geographies with country level break-up.

The companies are exploring the market by adopting expansions, investments, and new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Injection Lipolysis market throughout the predicted period.

Valeant Pharmaceuticals International, Inc. (United States), Allergan plc. (Ireland), Alma Lasers, Ltd. (Israel), Cynosure, Inc. (United States), Sciton, Inc. (United States), Solta Medical Inc. (United States), Lumenis Ltd. (Israel), Syneron Medical Ltd. (United States) and Apollo Cosmetic Clinics (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are VLCC Wellness (India), Lutronic Corporation (South Korea), Lynton Lasers Ltd (United Kingdom), EL.En. S.p.A. (Italy) and Cutera Inc. (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Injection Lipolysis market by Type, Application and Region.

On the basis of geography, the market of Injection Lipolysis has been segmented into .




Market Trend
  • Many Women Prefer Undergoing Cosmetic Surgery Rather Than Changing Their Lifestyle

Market Drivers
  • Growing Awareness Towards the fat Reduction Process
  • Increasing Population of Obese People
  • Increasing Demand for Non-Invasive Procedures
  • Demand for Cosmetic surgeries

Opportunities
  • Rise in Medical Tourism
  • Increase in Adoption of Body Contouring
  • High Market Potential in Untapped Emerging Economies

Restraints
  • Side Effects of Treatment

Challenges
  • High Cost of Treatment
  • Presence of Other Fat Breakdown Techniques


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Government Regulatory and Research Organizations, Raw Material Supliers and End-Use Industries

Frequently Asked Questions (FAQ):

1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Injection Lipolysis Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Report Objectives / Segmentation Covered
By Drug
  • Deoxycholic Acid
  • Phosphatidylcholine
  • Others

By Treatment Type
  • Facial Fat Deposits
  • Submental Fat
  • Upper Arm Fat
  • Abdominal Fat
  • Thighs Fat
  • Knee Fat
  • Buttock Fat
  • Others

By End User
  • Hospitals
  • Dermatology and Cosmetic Clinics
  • Ambulatory Surgical Centers

By Regions
    • 1. Market Overview
      • 1.1. Introduction
      • 1.2. Scope/Objective of the Study
        • 1.2.1. Research Objective
    • 2. Executive Summary
      • 2.1. Introduction
    • 3. Market Dynamics
      • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. Growing Awareness Towards the fat Reduction Process
        • 3.2.2. Increasing Population of Obese People
        • 3.2.3. Increasing Demand for Non-Invasive Procedures
        • 3.2.4. Demand for Cosmetic surgeries
      • 3.3. Market Challenges
        • 3.3.1. High Cost of Treatment
        • 3.3.2. Presence of Other Fat Breakdown Techniques
      • 3.4. Market Trends
        • 3.4.1. Many Women Prefer Undergoing Cosmetic Surgery Rather Than Changing Their Lifestyle
    • 4. Market Factor Analysis
      • 4.1. Porters Five Forces
      • 4.2. Supply/Value Chain
      • 4.3. PESTEL analysis
      • 4.4. Market Entropy
      • 4.5. Patent/Trademark Analysis
    • 5. Global Injection Lipolysis, by Drug, Treatment Type and End User (value) (2015-2020)
      • 5.1. Introduction
      • 5.2. Global Injection Lipolysis (Value)
        • 5.2.1. Global Injection Lipolysis by: Drug (Value)
          • 5.2.1.1. Deoxycholic Acid
          • 5.2.1.2. Phosphatidylcholine
          • 5.2.1.3. Others
        • 5.2.2. Global Injection Lipolysis by: Treatment Type (Value)
          • 5.2.2.1. Facial Fat Deposits
          • 5.2.2.2. Submental Fat
          • 5.2.2.3. Upper Arm Fat
          • 5.2.2.4. Abdominal Fat
          • 5.2.2.5. Thighs Fat
          • 5.2.2.6. Knee Fat
          • 5.2.2.7. Buttock Fat
          • 5.2.2.8. Others
        • 5.2.3. Global Injection Lipolysis by: End User (Value)
          • 5.2.3.1. Hospitals
          • 5.2.3.2. Dermatology and Cosmetic Clinics
          • 5.2.3.3. Ambulatory Surgical Centers
    • 6. Injection Lipolysis: Manufacturers/Players Analysis
      • 6.1. Competitive Landscape
        • 6.1.1. Market Share Analysis
          • 6.1.1.1. Top 3
          • 6.1.1.2. Top 5
      • 6.2. Peer Group Analysis (2020)
      • 6.3. BCG Matrix
      • 6.4. Company Profile
        • 6.4.1. Valeant Pharmaceuticals International, Inc. (United States)
          • 6.4.1.1. Business Overview
          • 6.4.1.2. Products/Services Offerings
          • 6.4.1.3. Financial Analysis
          • 6.4.1.4. SWOT Analysis
        • 6.4.2. Allergan plc. (Ireland)
          • 6.4.2.1. Business Overview
          • 6.4.2.2. Products/Services Offerings
          • 6.4.2.3. Financial Analysis
          • 6.4.2.4. SWOT Analysis
        • 6.4.3. Alma Lasers, Ltd. (Israel)
          • 6.4.3.1. Business Overview
          • 6.4.3.2. Products/Services Offerings
          • 6.4.3.3. Financial Analysis
          • 6.4.3.4. SWOT Analysis
        • 6.4.4. Cynosure, Inc. (United States)
          • 6.4.4.1. Business Overview
          • 6.4.4.2. Products/Services Offerings
          • 6.4.4.3. Financial Analysis
          • 6.4.4.4. SWOT Analysis
        • 6.4.5. Sciton, Inc. (United States)
          • 6.4.5.1. Business Overview
          • 6.4.5.2. Products/Services Offerings
          • 6.4.5.3. Financial Analysis
          • 6.4.5.4. SWOT Analysis
        • 6.4.6. Solta Medical Inc. (United States)
          • 6.4.6.1. Business Overview
          • 6.4.6.2. Products/Services Offerings
          • 6.4.6.3. Financial Analysis
          • 6.4.6.4. SWOT Analysis
        • 6.4.7. Lumenis Ltd. (Israel)
          • 6.4.7.1. Business Overview
          • 6.4.7.2. Products/Services Offerings
          • 6.4.7.3. Financial Analysis
          • 6.4.7.4. SWOT Analysis
        • 6.4.8. Syneron Medical Ltd. (United States)
          • 6.4.8.1. Business Overview
          • 6.4.8.2. Products/Services Offerings
          • 6.4.8.3. Financial Analysis
          • 6.4.8.4. SWOT Analysis
        • 6.4.9. Apollo Cosmetic Clinics (India)
          • 6.4.9.1. Business Overview
          • 6.4.9.2. Products/Services Offerings
          • 6.4.9.3. Financial Analysis
          • 6.4.9.4. SWOT Analysis
    • 7. Global Injection Lipolysis Sale, by Drug, Treatment Type and End User (value) (2021-2026)
      • 7.1. Introduction
      • 7.2. Global Injection Lipolysis (Value)
        • 7.2.1. Global Injection Lipolysis by: Drug (Value)
          • 7.2.1.1. Deoxycholic Acid
          • 7.2.1.2. Phosphatidylcholine
          • 7.2.1.3. Others
        • 7.2.2. Global Injection Lipolysis by: Treatment Type (Value)
          • 7.2.2.1. Facial Fat Deposits
          • 7.2.2.2. Submental Fat
          • 7.2.2.3. Upper Arm Fat
          • 7.2.2.4. Abdominal Fat
          • 7.2.2.5. Thighs Fat
          • 7.2.2.6. Knee Fat
          • 7.2.2.7. Buttock Fat
          • 7.2.2.8. Others
        • 7.2.3. Global Injection Lipolysis by: End User (Value)
          • 7.2.3.1. Hospitals
          • 7.2.3.2. Dermatology and Cosmetic Clinics
          • 7.2.3.3. Ambulatory Surgical Centers
    • 8. Appendix
      • 8.1. Acronyms
    • 9. Methodology and Data Source
      • 9.1. Methodology/Research Approach
        • 9.1.1. Research Programs/Design
        • 9.1.2. Market Size Estimation
        • 9.1.3. Market Breakdown and Data Triangulation
      • 9.2. Data Source
        • 9.2.1. Secondary Sources
        • 9.2.2. Primary Sources
      • 9.3. Disclaimer
    List of Tables
    • Table 1. Injection Lipolysis: by Drug(USD Million)
    • Table 2. Injection Lipolysis: by Treatment Type(USD Million)
    • Table 3. Injection Lipolysis: by End User(USD Million)
    • Table 4. Company Basic Information, Sales Area and Its Competitors
    • Table 5. Company Basic Information, Sales Area and Its Competitors
    • Table 6. Company Basic Information, Sales Area and Its Competitors
    • Table 7. Company Basic Information, Sales Area and Its Competitors
    • Table 8. Company Basic Information, Sales Area and Its Competitors
    • Table 9. Company Basic Information, Sales Area and Its Competitors
    • Table 10. Company Basic Information, Sales Area and Its Competitors
    • Table 11. Company Basic Information, Sales Area and Its Competitors
    • Table 12. Company Basic Information, Sales Area and Its Competitors
    • Table 13. Injection Lipolysis: by Drug(USD Million)
    • Table 14. Injection Lipolysis: by Treatment Type(USD Million)
    • Table 15. Injection Lipolysis: by End User(USD Million)
    • Table 16. Research Programs/Design for This Report
    • Table 17. Key Data Information from Secondary Sources
    • Table 18. Key Data Information from Primary Sources
    List of Figures
    • Figure 1. Porters Five Forces
    • Figure 2. Supply/Value Chain
    • Figure 3. PESTEL analysis
    • Figure 4. Global Injection Lipolysis: by Drug USD Million (2015-2020)
    • Figure 5. Global Injection Lipolysis: by Treatment Type USD Million (2015-2020)
    • Figure 6. Global Injection Lipolysis: by End User USD Million (2015-2020)
    • Figure 7. Global Injection Lipolysis share by Players 2020 (%)
    • Figure 8. Global Injection Lipolysis share by Players (Top 3) 2020(%)
    • Figure 9. Global Injection Lipolysis share by Players (Top 5) 2020(%)
    • Figure 10. BCG Matrix for key Companies
    • Figure 11. Valeant Pharmaceuticals International, Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 12. Valeant Pharmaceuticals International, Inc. (United States) Revenue: by Geography 2020
    • Figure 13. Allergan plc. (Ireland) Revenue, Net Income and Gross profit
    • Figure 14. Allergan plc. (Ireland) Revenue: by Geography 2020
    • Figure 15. Alma Lasers, Ltd. (Israel) Revenue, Net Income and Gross profit
    • Figure 16. Alma Lasers, Ltd. (Israel) Revenue: by Geography 2020
    • Figure 17. Cynosure, Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 18. Cynosure, Inc. (United States) Revenue: by Geography 2020
    • Figure 19. Sciton, Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 20. Sciton, Inc. (United States) Revenue: by Geography 2020
    • Figure 21. Solta Medical Inc. (United States) Revenue, Net Income and Gross profit
    • Figure 22. Solta Medical Inc. (United States) Revenue: by Geography 2020
    • Figure 23. Lumenis Ltd. (Israel) Revenue, Net Income and Gross profit
    • Figure 24. Lumenis Ltd. (Israel) Revenue: by Geography 2020
    • Figure 25. Syneron Medical Ltd. (United States) Revenue, Net Income and Gross profit
    • Figure 26. Syneron Medical Ltd. (United States) Revenue: by Geography 2020
    • Figure 27. Apollo Cosmetic Clinics (India) Revenue, Net Income and Gross profit
    • Figure 28. Apollo Cosmetic Clinics (India) Revenue: by Geography 2020
    • Figure 29. Global Injection Lipolysis: by Drug USD Million (2021-2026)
    • Figure 30. Global Injection Lipolysis: by Treatment Type USD Million (2021-2026)
    • Figure 31. Global Injection Lipolysis: by End User USD Million (2021-2026)
    Some of the key companies/manufacturers profiled in the report
    • Valeant Pharmaceuticals International, Inc. (United States)
    • Allergan plc. (Ireland)
    • Alma Lasers, Ltd. (Israel)
    • Cynosure, Inc. (United States)
    • Sciton, Inc. (United States)
    • Solta Medical Inc. (United States)
    • Lumenis Ltd. (Israel)
    • Syneron Medical Ltd. (United States)
    • Apollo Cosmetic Clinics (India)
    Additional players considered in the study are as follows:
    VLCC Wellness (India) , Lutronic Corporation (South Korea) , Lynton Lasers Ltd (United Kingdom) , EL.En. S.p.A. (Italy) , Cutera Inc. (United States)
    Select License Type
    Sample Report Enquiry Before Buy Request Discount

    Speak with Analyst

    Want to find out more about this report?

    Get Free Consultation